Zum Hauptinhalt springen

10th International Congress, Psoriasis: from Gene to Clinic

Considerable progress has been made over recent years in our understanding of psoriasis at both fundamental basic science and clinical levels. Identification of immunopathological mechanisms that lead to the expression of disease and elucidation of cellular processes which control proliferation and differentiation are integral to the development of new therapies and therapeutic approaches specifically designed for psoriasis. Furthermore, significant progress has been made in understanding the genetic architecture of psoriasis which in turn highlight key biological pathways, some shared with other auto-immune diseases. Emerging evidence suggests that psoriasis is associated with risk of cardiovascular disease and other comorbidities. The true relationships between these conditions and determination of mechanisms will be important in the long-term management of psoriasis.

Building on the success of our previous International Congresses held every three years since 1996, Psoriasis: from Gene to Clinic is designed to provide a forum for experts from around the world to present and discuss cutting edge issues. Delegates are anticipated to include clinicians, scientists and members of the biotechnology and pharmaceutical industries.

To reflect the areas of current scientific and clinical interests, the meeting will concentrate on specific plenary topics: genes and pathogenesis; inflammation and immunity, comorbidites and targeted therapeutics.

There will be plenty of opportunity for free communications on any aspect of psoriasis, either as oral or poster presentations. Time will be available for informal discussions. The high quality of the meeting is again reflected in our choice of venue. The Queen Elizabeth II Conference Centre is uniquely situated in the shadow of Big Ben and Westminster Abbey. The welcome reception will take place at the Conference Centre and the Congress Dinner will be held at the magnificent Science Museum, a unique, historic venue in the heart of London.

December is an excellent time to visit London and we hope that you will be able to join us.

Adressinfo:
Queen Elizabeth II Conference Centre
Straße:
Broad Sanctuary, Westminster
Plz:
SW1P 3EE
Ort:
London
Land:
United Kingdom
Veranstalter

International Psoriasis Council

Management

Co-Chairs
Jonathan Barker – London, UK
Christopher Griffiths – Manchester, UK

Scientific Committee
Herve Bachelez Paris, France
James Elder Ann Arbor, USA
Michel Gilliet Lausanne, Switzerland
Johann Gudjonsson, Ann Arbor, USA
Lars Iversen Aarhus, Denmark
James Krueger New York, USA
Errol Prens Rotterdam, The Netherlands
Jorg Prinz Munich, Germany
Catherine Smith London, UK
Peter van de Kerkhof Nijmegen, The Netherlands
Richard Warren Manchester, UK

Registrier-Email
conference@bad.org.uk
Zeitpunkt
05.12.2024 07:30 bis 07.12.2024 14:00
Autor
Organising Secretariat Conference and Event Services British Association of Dermatologists
Themen
TerminFortbildungsveranstaltungKonferenzSymposiumVortragWorkshopSeminarTagung
Quelle
https://psoriasisg2c.com
Webseite der Veranstaltung